glp 1 binge eating disorder Experts express alarm that GLP-1 RAs may trigger or worsen disorders. But is there any role they might play in eating disorder? And how can clinicians protect patients from risk? Ozempic, Wegovy, Zepbound — and

Introductory prices often increase to a standard recurring rate later

Enter GLP-1 Receptor Agonists Like Semaglutide and Tirzepatide GLP-1 (Glucagon-Like Peptide-1) receptor agonists were initially developed to treat type 2 diabetes

In clinical trials studying Wegovy (2.4 mg), the average weight loss was 15% and 20%, respectively, when paired with diet and exercise (compared to 2.4% and 3.1% with diet and exercise alone)

NAFLD is tightly associated with the global pandemic of obesity, metabolic syndrome (MS) and T2D, as well as with several genetic factors

(1) These statements have not been evaluated by the Food and Drug Administration

New Publication GLP-1 receptor agonists (GLP-1RAs), popular medications used for weight loss and the treatment of type 2 diabetes, have been increasingly prescribed in recent years, including to women of reproductive age